Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Ovarian Neoplasms

Free Subscription 09.09.2024 2 Br J Cancer 1 Gynecol Oncol 1 Int J Cancer 1 Lancet Oncol 1 PLoS Biol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Br J Cancer

1. KRISTELEIT R, Leary A, Oaknin A, Redondo A, et al
   PARP inhibition with rucaparib alone followed by combination with atezolizumab: Phase Ib COUPLET clinical study in advanced gynaecological and triple-negative breast cancers.
   Br J Cancer. 2024;131:820-831.
   PubMed         Abstract available
   
   
2. SMITH HL, Willmore E, Prendergast L, Curtin NJ, et al
   ATR, CHK1 and WEE1 inhibitors cause homologous recombination repair deficiency to induce synthetic lethality with PARP inhibitors.
   Br J Cancer. 2024;131:905-917.
   PubMed         Abstract available
   
   

   
   Gynecol Oncol

3. BHATNAGAR AR, Ghanem AI, Alkamachi B, Allo G, et al
   The prognostic impact of substantial lymphovascular space invasion in women with node negative FIGO stage I uterine carcinoma.
   Gynecol Oncol. 2024;188:44-51.
   PubMed         Abstract available
   
   

   
   Int J Cancer

4. NA R, Jordan SJ, DeFazio A, Williams M, et al
   Use of menopausal hormone therapy before and after diagnosis and ovarian cancer survival-A prospective cohort study in Australia.
   Int J Cancer. 2024 Sep 2. doi: 10.1002/ijc.35154.
   PubMed         Abstract available
   
   

   
   Lancet Oncol

5. MORICE P, Scambia G, Abu-Rustum NR, Acien M, et al
   Fertility-sparing treatment and follow-up in patients with cervical cancer, ovarian cancer, and borderline ovarian tumours: guidelines from ESGO, ESHRE, and ESGE.
   Lancet Oncol. 2024 Aug 28:S1470-2045(24)00262.
   PubMed         Abstract available
   
   

   
   PLoS Biol

6. EDWARDS F, Fantozzi G, Simon AY, Morretton JP, et al
   Centrosome amplification primes ovarian cancer cells for apoptosis and potentiates the response to chemotherapy.
   PLoS Biol. 2024;22:e3002759.
   PubMed         Abstract available
   
   

Thank you for your interest in scientific medicine.

AMEDEO Ovarian Neoplasms is free of charge.